C-Level Q&As  |
Discovery Series

Q&A With Malcolm Weir, Executive Vice Chairman of Sosei Heptares

01 November 2021
Join us as we sit down with Malcom Weir (Executive Vice Chairman, Sosei Heptares) to discuss the Drug Discovery landscape and recent therapeutic innovations.

Join us as we sit down with Malcom Weir (Executive Vice Chairman, Sosei Heptares) to discuss the Drug Discovery landscape and recent therapeutic innovations. This Q&A forms part of our CEO podcasts series, bringing you the latest insights from key industry leaders.

Share this article

Share on facebook
Share on twitter
Share on linkedin

Sign up for our monthly Discovery Newsletter

You may also be interested in...

Discussion Group Report
Our February Discovery Series discussion group centred on DNA Encoded Libraries (DEL). Using DEL enables the simultaneous screening of thousands of potential drugs against a target.
11 March 2022
Post-Event Report
This year’s Discovery Week: Online brought together over 800 discovery leaders to further innovation in drug discovery.
01 October 2021

Continue browsing

Share this article

Share on facebook
Share on twitter
Share on linkedin

Join our Discovery mailing list

We produce cutting edge congresses and summits for the Life Sciences Industry, bringing together industry leaders and solution providers at a senior level, creating the opportunity to partner, network and knowledge share.

Contact Us:

Copyright Oxford Global Marketing Limited. All rights reserved.

Member Community Login

Stay up to date

Sign up for our monthly Editorial Newsletter to keep up with all things Discovery